Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Schulz Menger, Jeanette ^a   Bluemke, David A ^d   Bremerich, Jens ^j   Flamm, Scott D ^c   Fogel, Mark A ⁱ   Friedrich, Matthias G ^g   Kim, Raymond J ^f   Von Knobelsdorff Brenkenhoff, Florian ^a   Kramer, Christopher M ^b   Pennell, Dudley J ^h   Plein, Sven ^e   Nagel, Eike ^k  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f DUKE UNIVERSITY   (United States)

^g MONTREAL HEART INSTITUTE   (Canada)

^h ROYAL BROMPTON HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

^k KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Heart; Image interpretation; Magnetic resonance imaging; Post processing; Recommendations

Indexed keywords

GADOLINIUM;

ALGORITHM; ANGIOGRAPHY; ARTICLE; BLOOD VOLUME; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIFFUSION WEIGHTED IMAGING; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART PAPILLARY MUSCLE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; INFORMATION PROCESSING; LUNG VEIN; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; PULMONARY ARTERY; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; THORACIC AORTA;

CARDIOVASCULAR DISEASES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY OF RESULTS;

EID: 84876805792     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-35     Document Type: Article

References (69)

1. ACCF/ACR/AHA/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR 2008 health policy statement on structured reporting in cardiovascular imaging. Douglas PS, Hendel RC, Cummings JE, Dent JM, Hodgson JM, Hoffmann U, Horn RJ 3rd, Hundley WG, Kahn CE Jr, Martin GR, Masoudi FA, Peterson ED, Rosenthal GL, Solomon H, Stillman AE, Teague SD, Thomas JD, Tilkemeier PL, Guy Weigold W, J Am Coll Cardiol 2009 53 76 90 10.1016/j.jacc.2008.09.005 19118730
2. Society for cardiovascular magnetic resonance guidelines for reporting cardiovascular magnetic resonance examinations. Hundley WG, Bluemke D, Bogaert JG, Friedrich MG, Higgins CB, Lawson MA, McConnell MV, Raman SV, van Rossum AC, Flamm S, Kramer CM, Nagel E, Neubauer S, J Cardiovasc Magn Reson 2009 11 5 10.1186/1532-429X-11-5 19257889
3. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK, J Cardiovasc Magn Reson 2004 6 727 765 10.1081/JCMR-200038581 15646878
4. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. Hendel RC, Patel MR, Kramer CM, Poon M, Carr JC, Gerstad NA, Gillam LD, Hodgson JM, Kim RJ, Lesser JR, Martin ET, Messer JV, Redberg RF, Rubin GD, Rumsfeld JS, Taylor AJ, Weigold WG, Woodard PK, Brindis RG, Douglas PS, Peterson ED, Wolk MJ, Allen JM, J Am Coll Cardiol 2006 48 1475 1497 10.1016/j.jacc.2006.07.003 17010819
5. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM, Manning WJ, Patel M, Pohost GM, Stillman AE, White RD, Woodard PK, J Am Coll Cardiol 2010 55 2614 2662 10.1016/j.jacc.2009.11.011 20513610
6. Standardized cardiovascular magnetic resonance imaging (CMR) protocols. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, J Cardiovasc Magn Reson 2008 10 35 10.1186/1532-429X-10-35 18605997
7. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Circulation 2002 105 539 542 10.1161/hc0402.102975 11815441
8. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. Maceira AM, Prasad SK, Khan M, Pennell DJ, J Cardiovasc Magn Reson 2006 8 417 426 10.1080/ 10976640600572889 16755827
9. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S, J Cardiovasc Magn Reson 2005 7 775 782 10.1080/10976640500295516 16353438
10. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. Natori S, Lai S, Finn JP, Gomes AS, Hundley WG, Jerosch-Herold M, Pearson G, Sinha S, Arai A, Lima JA, Bluemke DA, AJR Am J Roentgenol 2006 186 357 S365 10.2214/AJR.04.1868 16714609
11. Improved quantitative assessment of left ventricular volumes using TGrE approach after application of extracellular contrast agent at 3 Tesla. Hamdan A, Kelle S, Schnackenburg B, Fleck E, Nagel E, J Cardiovasc Magn Reson 2007 9 845 853 10.1080/10976640701693600 18066743
12. Silverman D, Manning W, The Complete Guide to Echocardiography Sudbury, MA: Jones and Bartlett 2012
13. Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession. Thiele H, Paetsch I, Schnackenburg B, Bornstedt A, Grebe O, Wellnhofer E, Schuler G, Fleck E, Nagel E, J Cardiovasc Magn Reson 2002 4 327 339 10.1081/JCMR-120013298 12234104
14. Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. Puntmann VO, Gebker R, Duckett S, Mirelis J, Schnackenburg B, Graefe M, Razavi R, Fleck E, Nagel E, Eur Heart J Cardiovasc Imaging 2013 14 240 246 10.1093/ehjci/jes145 22815376
15. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU, J Magn Reson Imaging 2003 17 323 329 10.1002/jmri.10262 12594722
16. Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging. Alfakih K, Plein S, Bloomer T, Jones T, Ridgway J, Sivananthan M, J Magn Reson Imaging 2003 18 25 32 10.1002/jmri.10329 12815636
17. Assessment of the accuracy and reproducibility of RV volume measurements by CMR in congenital heart disease. Clarke CJ, Gurka MJ, Norton PT, Kramer CM, Hoyer AW, JACC Cardiovasc Imaging 2012 5 28 37 10.1016/j.jcmg.2011.05.007 22239890
18. On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Di Bella EV, Parker DL, Sinusas AJ, Magn Reson Med 2005 54 1295 1299 10.1002/mrm.20666 16200553
19. Added value of rest to stress study for recognition of artifacts in perfusion cardiovascular magnetic resonance. Thomson LE, Fieno DS, Abidov A, Slomka PJ, Hachamovitch R, Saouaf R, Friedman JD, Berman DS, J Cardiovasc Magn Reson 2007 9 733 740 10.1080/10976640701544415 17891609
20. Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease. Chung SY, Lee KY, Chun EJ, Lee WW, Park EK, Chang HJ, Choi SI, AJR Am J Roentgenol 2010 195 356 362 10.2214/AJR.08.1839 20651190
21. Assessment of subendocardial structure and function. Stanton T, Marwick TH, JACC Cardiovasc Imaging 2010 3 867 875 10.1016/j.jcmg.2010.05.011 20705269
22. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ, N Engl J Med 2002 346 1948 1953 10.1056/NEJMoa012369 12075055
23. Angiographic correlations of patients with small vessel disease diagnosed by adenosine-stress cardiac magnetic resonance imaging. Pilz G, Klos M, Ali E, Hoefling B, Scheck R, Bernhardt P, J Cardiovasc Magn Reson 2008 10 8 10.1186/1532-429X-10-8 18275591
24. Myocardial perfusion in hypertensive patients with normal coronary angiograms. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Klecha A, Kwiecien-Sobstel A, Stolarz-Skrzypek K, Pennell DJ, Pasowicz M, Klimeczek P, Banys RP, J Hypertens 2008 26 1686 1694 10.1097/HJH.0b013e328303df42 18622249
25. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, Cawley P, Parker M, Elliott M, Judd RM, Kim RJ, J Am Coll Cardiol 2006 47 1630 1638 10.1016/j.jacc.2005.10.074 16631001
26. Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance. Karamitsos TD, Ntusi NA, Francis JM, Holloway CJ, Myerson SG, Neubauer S, J Cardiovasc Magn Reson 2010 12 66 10.1186/1532-429X-12-66 21080924
27. Quantification of myocardial perfusion by cardiovascular magnetic resonance. Jerosch-Herold M, J Cardiovasc Magn Reson 2010 12 57 10.1186/1532-429X-12-57 20932314
28. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Schwitter J, DeMarco T, Kneifel S, von Schulthess GK, Jorg MC, Arheden H, Ruhm S, Stumpe K, Buck A, Parmley WW, Luscher TF, Higgins CB, Circulation 2000 101 2696 2702 10.1161/01.CIR.101.23.2696 10851206
29. Evaluation of contrast wash-in and peak enhancement in adenosine first pass perfusion CMR in patients post bypass surgery. Kelle S, Graf K, Dreysse S, Schnackenburg B, Fleck E, Klein C, J Cardiovasc Magn Reson 2010 12 28 10.1186/1532-429X-12-28 20465836
30. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Rieber J, Huber A, Erhard I, Mueller S, Schweyer M, Koenig A, Schiele TM, Theisen K, Siebert U, Schoenberg SO, Reiser M, Klauss V, Eur Heart J 2006 27 1465 1471 16720685
31. Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Klocke FJ, Simonetti OP, Judd RM, Kim RJ, Harris KR, Hedjbeli S, Fieno DS, Miller S, Chen V, Parker MA, Circulation 2001 104 2412 2416 10.1161/hc4501.099306 11705817
32. Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group. Jerosch-Herold M, Wilke N, Wang Y, Gong GR, Mansoor AM, Huang H, Gurchumelidze S, Stillman AE, Int J Card Imaging 1999 15 453 464 10.1023/A:1006368619112 10768740
33. Myocardial blood flow quantification with MRI by model-independent deconvolution. Jerosch-Herold M, Swingen C, Seethamraju RT, Medical physics 2002 29 886 897 10.1118/1.1473135 12033585
34. How we perform delayed enhancement imaging. Kim RJ, Shah DJ, Judd RM, J Cardiovasc Magn Reson 2003 5 505 514 10.1081/JCMR-120022267 12882082
35. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ, Circulation 2003 108 54 59 10.1161/01.CIR.0000078641.19365.4C 12821550
36. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ, Eur Heart J 2005 26 1461 1474 10.1093/eurheartj/ehi258 15831557
37. Optimizing cardiac MR imaging: practical remedies for artifacts. Saremi F, Grizzard JD, Kim RJ, Radiographics 2008 28 1161 1187 10.1148/rg.284065718 18635635
38. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magn Reson Med 2002 47 372 383 10.1002/mrm.10051 11810682
39. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG, Visser CA, van Rossum AC, J Cardiovasc Magn Reson 2005 7 481 485 10.1081/JCMR-200053623 15881532
40. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. Amado LC, Gerber BL, Gupta SN, Rettmann DW, Szarf G, Schock R, Nasir K, Kraitchman DL, Lima JA, J Am Coll Cardiol 2004 44 2383 2389 10.1016/j.jacc.2004.09.020 15607402
41. Quantitative myocardial infarction on delayed enhancement MRI. Part I: animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. Hsu LY, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE, J Magn Reson Imaging 2006 23 298 308 10.1002/jmri.20496 16450367
42. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC, JACC Cardiovasc Imaging 2011 4 150 156 10.1016/j.jcmg.2010.11.015 21329899
43. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. Kim HW, Farzaneh-Far A, Kim RJ, J Am Coll Cardiol 2009 55 1 16 10.1016/j.jacc.2009.06.059 20117357
44. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marban E, Tomaselli GF, Lima JA, Wu KC, Circulation 2007 115 2006 2014 10.1161/CIRCULATIONAHA.106.653568 17389270
45. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY, Circulation 2006 114 32 39 10.1161/CIRCULATIONAHA.106.613414 16801462
46. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP, Magn Reson Med 2004 52 141 146 10.1002/mrm.20110 15236377
47. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, J Am Coll Cardiol 2008 52 1574 1580 10.1016/j.jacc.2008.06.049 19007595
48. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE, Am J Physiol Heart Circ Physiol 2008 295 1234 H1242 10.1152/ajpheart.00429.2008 18660445
49. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Circulation 2010 122 138 144 10.1161/CIRCULATIONAHA.109.930636 20585010
50. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P, J Am Coll Cardiol 2009 53 1475 1487 10.1016/j.jacc.2009.02.007 19389557
51. Characterizing Myocardial Edema and Hemorrhage Using Quantitative T2 and T2* Mapping at Multiple Time Intervals Post ST-Segment Elevation Myocardial Infarction. Zia MI, Ghugre NR, Connelly KA, Strauss BH, Sparkes JD, Dick AJ, Wright GA, Circ Cardiovasc Imaging 2012 5 566 572 10.1161/CIRCIMAGING. 112.973222 22744938
52. Myocardial T*2 measurement in iron-overloaded thalassemia: an ex vivo study to investigate optimal methods of quantification. He T, Gatehouse PD, Kirk P, Mohiaddin RH, Pennell DJ, Firmin DN, Magn Reson Med 2008 60 350 356 10.1002/mrm.21625 18666131
53. Myocardial T2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN, Magn Reson Med 2008 60 1082 1089 10.1002/mrm.21744 18956471
54. Black-blood T2* technique for myocardial iron measurement in thalassemia. He T, Gatehouse PD, Kirk P, Tanner MA, Smith GC, Keegan J, Mohiaddin RH, Pennell DJ, Firmin DN, J Magn Reson Imaging 2007 25 1205 1209 10.1002/jmri.20929 17520740
55. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ, Eur Heart J 2001 22 2171 2179 10.1053/euhj.2001.2822 11913479
56. On T2* magnetic resonance and cardiac iron. Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, Galanello R, Forni G, Catani G, Matta G, Fucharoen S, Fleming A, House MJ, Black G, Firmin DN, St Pierre TG, Pennell DJ, Circulation 2011 123 1519 1528 10.1161/CIRCULATIONAHA.110.007641 21444881
57. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJ, Circulation 2009 120 1961 1968 10.1161/CIRCULATIONAHA.109.874487 19801505
58. Magnetic resonance volume flow and jet velocity mapping in aortic coarctation. Mohiaddin RH, Kilner PJ, Rees S, Longmore DB, J Am Coll Cardiol 1993 22 1515 1521 10.1016/0735-1097(93)90565-I 8227813
59. MR blood flow measurement. Clinical application in the heart and circulation. Mohiaddin RH, Pennell DJ, Cardiol Clin 1998 16 161 187 10.1016/S0733-8651(05)70007-2 9627755
60. Magnetic resonance measurement of velocity and flow: technique, validation, and cardiovascular applications. Rebergen SA, van der Wall EE, Doornbos J, de Roos A, Am Heart J 1993 126 1439 1456 10.1016/0002-8703(93)90544- J 8249802
61. MRI phase contrast velocity and flow errors in turbulent stenotic jets. O'Brien KR, Cowan BR, Jain M, Stewart RA, Kerr AJ, Young AA, J Magn Reson Imaging 2008 28 210 218 10.1002/jmri.21395 18581344
62. Baseline correction of phase-contrast images in congenital cardiovascular magnetic resonance. Holland BJ, Printz BF, Lai WW, J Cardiovasc Magn Reson 2010 12 11 10.1186/1532-429X-12-11 20205725
63. Baseline correction of phase contrast images improves quantification of blood flow in the great vessels. Chernobelsky A, Shubayev O, Comeau CR, Wolff SD, J Cardiovasc Magn Reson 2007 9 681 685 10.1080/10976640601187588 17578724
64. Flow measurement by cardiovascular magnetic resonance: a multi-centre multi-vendor study of background phase offset errors that can compromise the accuracy of derived regurgitant or shunt flow measurements. Gatehouse PD, Rolf MP, Graves MJ, Hofman MB, Totman J, Werner B, Quest RA, Liu Y, von Spiczak J, Dieringer M, Firmin DN, van Rossum A, Lombardi M, Schwitter J, Schulz-Menger J, Kilner PJ, J Cardiovasc Magn Reson 2010 12 5 10.1186/1532-429X-12-5 20074359
65. Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Lotz J, Meier C, Leppert A, Galanski M, Radiographics 2002 22 651 671 12006694
66. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM, J Am Coll Cardiol 2010 55 27 e129 10.1016/j.jacc.2010.02.015 20359588
67. Imaging of thoracic aortic disease. Holloway BJ, Rosewarne D, Jones RG, Br J Radiol 2011 84 Spec No 3 338 S354 22723539
68. MR imaging of pulmonary embolism: diagnostic accuracy of contrast-enhanced 3D MR pulmonary angiography, contrast-enhanced low-flip angle 3D GRE, and nonenhanced free-induction FISP sequences. Kalb B, Sharma P, Tigges S, Ray GL, Kitajima HD, Costello JR, Chen Z, Martin DR, Radiology 2012 263 271 278 10.1148/radiol.12110224 22438448
69. Anatomical and functional evaluation of pulmonary veins in children by magnetic resonance imaging. Grosse-Wortmann L, Al-Otay A, Goo HW, Macgowan CK, Coles JG, Benson LN, Redington AN, Yoo SJ, J Am Coll Cardiol 2007 49 993 1002 10.1016/j.jacc.2006.09.052 17336724